Manufacturer's investigation conclusion: the evaluation of the returned device confirmed a damaged fiber that would have caused the reported blood leak.The eurosets amg pmp oxygenator, lot number 5969906, was returned to abbott and an initial visual inspection was performed.Visual inspection of the oxygenator revealed blood within the orange housing of the device near the gas outlet port, indicative of leakage.No obvious damage to the external housing, ports, or fibers was observed.The oxygenator was then forwarded to the external manufacturer for technical analysis.The oxygenator was cleaned of blood contamination then pressurized at 1 atmosphere (atm) and no leaks were immediately detected.The test circuit was then filled with physiological water and an initial flow of 4 liters per minute (lpm) was established.The oxygenator operated in the test loop for 3 hours and dripping was observed within the lower part of the oxygenator.In order to identify the exact point of leakage, the device was cut into sections by removing the heat exchanger and the gas-in and gas-out lid.Traces of clotted blood were observed that appeared to be a consequence of blood leakage due to a broken fiber.A specific root cause for the damage to the fiber that caused the reported leaking could not be conclusively determined through the manufacturer investigation.Production documentation was reviewed by the manufacturer and all tests from the production process were compliant with the technical specifications, suggesting that the damage occurred after production of the device.The production documentation for amg pmp oxygenator, lot number 5969906, was reviewed by the external manufacturer and showed that all tests from the production process were compliant with the technical specifications.The eurosets amg pmp instructions for use (ifu) is currently available.Under the list of warnings, the ifu warns that during the extracorporeal circulation (ecc) a backup oxygenator is necessary and also warns that the extracorporeal circulation has to be carefully and continuously checked.Also under the list of warnings, the ifu warns that ¿before using the product it is advisable to carefully inspect it.Shipping and handling could cause structural and functional damage to the device.¿ the section "during bypass" warns that the act (activated coagulation time) must always be longer than or equal to 480 seconds in order to ensure adequate anticoagulation of the extracorporeal circuit.Under the section titled ¿oxygenator replacement¿, this document states that a spare oxygenator must always be available during perfusion.After 6 hours of use with blood or if particular situations occur, which may lead the person responsible for perfusion to determine the safety of the patient may be compromised (insufficient oxygenator performance, leaks, abnormal blood parameters, etc.), follow the procedure outlined in the ifu for oxygenator replacement.No further information was provided.The manufacturer is closing the file on this event.
|